An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China

J Infect. 2022 Jan;84(1):e21-e22. doi: 10.1016/j.jinf.2021.10.020. Epub 2021 Oct 30.

Authors

Jin Wang¹, Heng Zou², Christopher Corpe³

Affiliations

¹ Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Road, Shanghai, China. Electronic address: [email protected].
² Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Road, Shanghai, China.
³ Nutritional Science Department, King's College London, 150 Stamford Street, Waterloo, London SE19NH, United Kingdom.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme 2
Angiotensin-Converting Enzyme Inhibitors
COVID-19*
Humans
SARS-CoV-2

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Angiotensin-Converting Enzyme 2